Cellebrite DI Ltd.

94 Shlomo Shmelzer Road

Petah Tikva, Israel


October 4, 2021


U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F Street, NE
Washington, D.C. 20549


Attn: Jan Woo
  Matthew Crispino
Re: Cellebrite DI Ltd.
  Registration Statement on Form F-1
  Filed September 27, 2021, as amended
  File No. 333-259826


Dear Ms. Woo and Mr. Crispino:


Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Cellebrite DI Ltd. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on October 6, 2021, or as soon thereafter as practicable.


Please call Colin Diamond of White & Case LLP at (212) 819-8754 to provide notice of the effectiveness of the Registration Statement.



[Signature Page Follows]





  Very truly yours,
  Cellebrite DI Ltd.
  By:  /s/ Yossi Carmil



Yossi Carmil
Chief Executive Officer



cc: Dana Gerner, Cellebrite DI Ltd.

Colin Diamond, White & Case LLP